Health-related quality of life (HRQoL) at final analysis of the GALAHAD study of niraparib in patients with metastatic castration-resistant prostate cancer (mCRPC) and DNA repair defects (DRD)
dc.conference.date | SEP 16-21, 2021 | |
dc.conference.title | Congress of the European-Society-for-Medical-Oncology (ESMO) | |
dc.contributor.author | Smith, M. R. | |
dc.contributor.author | Sandhu, S. K. | |
dc.contributor.author | George, D. J. | |
dc.contributor.author | Chi, K. N. | |
dc.contributor.author | Saad, F. | |
dc.contributor.author | Thiery-Vuillemin, A. | |
dc.contributor.author | Stahl, O. | |
dc.contributor.author | Olmos, D. | |
dc.contributor.author | Danila, D. | |
dc.contributor.author | Gafanov, R. | |
dc.contributor.author | Castro, E. | |
dc.contributor.author | Moon, H. | |
dc.contributor.author | Joshua, A. M. | |
dc.contributor.author | Mason, G. E. | |
dc.contributor.author | Espina, B. M. | |
dc.contributor.author | Liu, Y. | |
dc.contributor.author | Bevans, K. B. | |
dc.contributor.author | Lopez-Gitlitz, A. | |
dc.contributor.author | Francis, P. | |
dc.contributor.author | Fizazi, K. | |
dc.contributor.authoraffiliation | [Smith, M. R.] Massachusetts Gen Hosp, Med Oncol, Canc Ctr, Boston, MA USA | |
dc.contributor.authoraffiliation | [Smith, M. R.] Harvard Med Sch, Boston, MA 02115 USA | |
dc.contributor.authoraffiliation | [Sandhu, S. K.] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia | |
dc.contributor.authoraffiliation | [George, D. J.] Duke Univ, Duke Canc Inst, Sch Med, Durham, NC USA | |
dc.contributor.authoraffiliation | [Chi, K. N.] BC Canc Agcy, Dept Med Oncol, Vancouver, BC, Canada | |
dc.contributor.authoraffiliation | [Saad, F.] Univ Montreal, Ctr Hosp Univ Montreal, Montreal, PQ, Canada | |
dc.contributor.authoraffiliation | [Thiery-Vuillemin, A.] CHRU Besancon Hop Jean Minjoz, Dept Med Oncol, Besancon, France | |
dc.contributor.authoraffiliation | [Stahl, O.] Skane Univ Hosp, Dept Oncol, Lund, Sweden | |
dc.contributor.authoraffiliation | [Olmos, D.] Spanish Natl Canc Res Ctr CNIO, Dept Med Oncol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Danila, D.] Mem Sloan Kettering Canc Ctr, Med Oncol, 1275 York Ave, New York, NY 10021 USA | |
dc.contributor.authoraffiliation | [Gafanov, R.] Russian Sci Ctr Roentgenoradiol, Med Oncol, Moscow, Russia | |
dc.contributor.authoraffiliation | [Castro, E.] Hosp Virgen Victoria, Dept Med Oncol, Malaga, Spain | |
dc.contributor.authoraffiliation | [Moon, H.] Kaiser Permanente Southern Calif, Hematol Oncol, Riverside, CA USA | |
dc.contributor.authoraffiliation | [Joshua, A. M.] St Vincents Hosp Sydney, Kinghorn Canc Ctr, Darlinghurst, NSW, Australia | |
dc.contributor.authoraffiliation | [Mason, G. E.] Janssen Res & Dev, Clin Oncol, Spring House, PA USA | |
dc.contributor.authoraffiliation | [Espina, B. M.] Janssen Res & Dev, Clin Oncol, Los Angeles, CA USA | |
dc.contributor.authoraffiliation | [Lopez-Gitlitz, A.] Janssen Res & Dev, Clin Oncol, Los Angeles, CA USA | |
dc.contributor.authoraffiliation | [Liu, Y.] Janssen Global Commercial Strat Org, Horsham, PA USA | |
dc.contributor.authoraffiliation | [Bevans, K. B.] Janssen Global Commercial Strat Org, Horsham, PA USA | |
dc.contributor.authoraffiliation | [Francis, P.] Janssen Res & Dev, New Brunswick, NJ USA | |
dc.contributor.authoraffiliation | [Fizazi, K.] Univ Paris Saclay, Inst Gustave Roussy, Dept Med Oncol, Villejuif, France | |
dc.contributor.funder | Janssen Research Development | |
dc.date.accessioned | 2025-01-07T15:20:58Z | |
dc.date.available | 2025-01-07T15:20:58Z | |
dc.date.issued | 2021-09-21 | |
dc.identifier.doi | 10.1016/j.annonc.2021.08.1095 | |
dc.identifier.essn | 1569-8041 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.unpaywallURL | http://www.annalsofoncology.org/article/S092375342103324X/pdf | |
dc.identifier.uri | https://hdl.handle.net/10668/27059 | |
dc.identifier.wosID | 700527701046 | |
dc.issue.number | 5 | |
dc.journal.title | Annals of oncology | |
dc.journal.titleabbreviation | Ann. oncol. | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Virgen de la Victoria | |
dc.organization | SAS - Hospital Universitario Virgen de la Victoria | |
dc.page.number | S632-S633 | |
dc.publisher | Elsevier | |
dc.rights.accessRights | open access | |
dc.title | Health-related quality of life (HRQoL) at final analysis of the GALAHAD study of niraparib in patients with metastatic castration-resistant prostate cancer (mCRPC) and DNA repair defects (DRD) | |
dc.type | conference output | |
dc.type.hasVersion | VoR | |
dc.volume.number | 32 | |
dc.wostype | Meeting Abstract |